三方基因蛋白6通过多种途径促进肝细胞癌的进展
Yifeng Zhang1, Lin Yuan2, Shanshan Cui3
1Division of Digestive System, Department of Internal Medicine, The Second Affiliated Hospital, Shandong First Medical University, Tai'an, China.
三方基因含有6 (TRIM6) 蛋白的高表达与肝细胞癌 (HCC) 的预后不佳相关. 通过影响扩散,入侵和血管生成,TRIM6促进了HCC的进展,这表明其作为预后因素的潜力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生化学
背景情况:
- 肝细胞癌 (HCC) 是全球癌症死亡的主要原因.
- 含三重动机 (TRIM) 蛋白质家族在癌症的发展中起作用.
- 在HCC中TRIM6的特殊作用需要进一步阐明.
研究的目的:
- 为了研究TRIM6在HCC中的表达特征.
- 确定TRIM6在HCC预后中的临床意义.
- 探索TRIM6在HCC中的作用的基本机制.
主要方法:
- 对138名HCC患者的回顾性分析.
- 对于TRIM6蛋白质表达的免疫组织化学染色.
- 在HCC细胞系 (Huh7,Hep3B) 中进行了体外淘汰和过度表达试验.
- 在裸体小鼠体内异种移植模型.
主要成果:
- 与非瘤组织相比,HCC组织中TRIM6的调节显著增加.
- 提升的TRIM6表达与较大的瘤大小,晚期和较差的患者存活率相关.
- TRIM6的淘汰抑制了HCC细胞的增殖,入侵和血管生成,而过度表达促进了这些过程.
- 受到TRIM6影响的关键下游目标包括cyclin B1,c-Myc,Snail,MMP2和VEGF-A.
结论:
- TRIM6在HCC中高度表达,并作为潜在的预后生物标志物.
- TRIM6通过多个信号通路促进HCC的进展,影响细胞增殖,入侵和血管生成.
更多相关视频
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
08:40A Biomimetic Model for Liver Cancer to Study Tumor-Stroma Interactions in a 3D Environment with Tunable Bio-Physical Properties
Published on: August 7, 2020
相关概念视频
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway
MAPK Signaling Cascades
Abnormal Proliferation
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
